Get the Stockscreener App
0.7975
44.23%
-0.6325
After Hours:
.79
-0.0075
-0.94%
Verrica Pharmaceuticals Inc Stock (VRCA) Forecast
The Verrica Pharmaceuticals Inc (VRCA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $13.60, representing a +1,606% increase from the current price of $0.7975. The highest analyst price target is $16.43, and the lowest is $10.77.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VRCA Price Target
Average 10.15
(+1,173% Upside)
Is Verrica Pharmaceuticals Inc (VRCA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 27.57 | Buy |
| STOCH(9,6) | 33.36 | Neutral |
| STOCHRSI(14) | 25.88 | Neutral |
| MACD(12,26) | -0.1404 | Sell |
| ADX(14) | 26.83 | Sell |
| William %R | -94.92 | Buy |
| CCI(14) | -433.33 | Sell |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.4518
Sell
|
1.3789
Sell
|
| MA20 |
1.4484
Sell
|
1.4648
Sell
|
| MA50 |
1.6766
Sell
|
2.1027
Sell
|
| MA100 |
3.9972
Sell
|
3.3185
Sell
|
| MA200 |
5.2972
Sell
|
4.3337
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, VRCA could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 13 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on VRCA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 27.57 indicates that VRCA is oversold. This indicates that VRCA price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 33.36 indicates that VRCA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 25.88 indicates that VRCA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.83 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -433.33 indicates that VRCA is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term VRCA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Verrica Pharmaceuticals Inc financial reports and earnings history, Verrica Pharmaceuticals Inc (VRCA) stock could reach $5.5697 by 2030, $1.381 by 2040 and $1.6277 by 2050. See the projected annual prices until 2050 of the Verrica Pharmaceuticals Inc stock below:
- Verrica Pharmaceuticals Inc (VRCA) is expected to reach an average price of $0.2262 in 2035, with a high prediction of $0.5444 and a low estimate of $0.0256. This indicates an $-71.64% rise from the last recorded price of $0.7975.
- Verrica Pharmaceuticals Inc (VRCA) stock is projected to chart a bullish course in 2040, with an average price target of $0.6387, representing an $-19.92% surge from its current level. The forecast ranges from a conservative $0.1087 to a sky-high $1.381.
- Our analysts predict Verrica Pharmaceuticals Inc (VRCA) to jump 552.63% by 2045, soaring from $4.0883 to an average price of $5.2047, potentially reaching $4.4426. While $4.0883 is the low estimate, the potential upside is significant.
- Verrica Pharmaceuticals Inc (VRCA) stock is expected to climb by 2050, reaching an average of $1.2578, a $57.72% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1.6277 and $1.9973, respectively, highlighting the market's uncertainty.
Verrica Pharmaceuticals Inc Stock (VRCA) Year by Year Forecast
Verrica Pharmaceuticals Inc Stock (VRCA) Price Forecast for 2024
Our forecast for VRCA stock price in 2024 now indicates an average price target of $10.50 with a high forecast of $16.43 and a low forecast of $4.5579. The average prediction reflects an increase of +1,216% from the last recorded price of $0.7975.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $11.66 | $10.77 | $16.43 | +1,363% |
Verrica Pharmaceuticals Inc Stock (VRCA) Price Forecast for 2025
Verrica Pharmaceuticals Inc Stock (VRCA) is expected to reach an average price of $9.5871 in 2025, with a high prediction of $15.31 and a low estimate of $3.8636. This indicates an +1,102% rise from the last recorded price of $0.7975.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $12.94 | $10.37 | $14.93 | +1,523% |
| February, 2025 | $12.26 | $11.81 | $15.31 | +1,438% |
| March, 2025 | $9.5505 | $8.8505 | $13.58 | +1,098% |
| April, 2025 | $7.8203 | $4.6964 | $10.54 | +880.60% |
| May, 2025 | $8.2182 | $6.8023 | $9.9262 | +930.49% |
| June, 2025 | $8.076 | $7.316 | $10.95 | +912.67% |
| July, 2025 | $11.42 | $7.798 | $12.33 | +1,331% |
| August, 2025 | $7.3737 | $6.1337 | $13.71 | +824.60% |
| September, 2025 | $4.5016 | $3.9716 | $7.9257 | +464.46% |
| October, 2025 | $6.2514 | $3.8636 | $9.0955 | +683.88% |
| November, 2025 | $5.5993 | $5.2593 | $7.6354 | +602.10% |
| December, 2025 | $5.2791 | $4.9191 | $7.3332 | +561.96% |
Verrica Pharmaceuticals Inc Stock (VRCA) Price Forecast for 2026
The predicted value for Verrica Pharmaceuticals Inc (VRCA) in 2026 is set at an average of $9.2267. Estimates vary from a peak of $16.33 to a trough of $2.125, indicating an +1,057% surge from the present price of $0.7975.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $7.297 | $2.125 | $7.8445 | +814.98% |
| February, 2026 | $8.4548 | $6.7089 | $9.1348 | +960.17% |
| March, 2026 | $8.7827 | $8.0568 | $11.44 | +1,001% |
| April, 2026 | $12.80 | $8.8047 | $14.81 | +1,505% |
| May, 2026 | $13.74 | $10.69 | $16.33 | +1,623% |
| June, 2026 | $11.68 | $10.42 | $14.92 | +1,364% |
| July, 2026 | $9.6281 | $8.8831 | $12.27 | +1,107% |
| August, 2026 | $8.426 | $7.534 | $10.03 | +956.55% |
| September, 2026 | $8.3158 | $8.0158 | $10.55 | +942.73% |
| October, 2026 | $8.5737 | $7.9497 | $9.8197 | +975.07% |
| November, 2026 | $9.1615 | $7.2076 | $9.8615 | +1,049% |
| December, 2026 | $10.48 | $7.1894 | $12.75 | +1,214% |
Verrica Pharmaceuticals Inc Stock (VRCA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Verrica Pharmaceuticals Inc (VRCA) is $5.8196, with a high forecast of $11.62 and a low forecast of $0.0218. This indicates an +629.72% increase from the last price of $0.7975.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $10.77 | $9.8053 | $11.62 | +1,250% |
| February, 2027 | $9.4271 | $8.4671 | $11.52 | +1,082% |
| March, 2027 | $7.0969 | $6.501 | $10.06 | +789.90% |
| April, 2027 | $6.3248 | $6.1598 | $7.9509 | +693.08% |
| May, 2027 | $5.8327 | $5.1087 | $6.6268 | +631.37% |
| June, 2027 | $6.1625 | $5.6356 | $6.8525 | +672.73% |
| July, 2027 | $6.1404 | $5.4745 | $6.8384 | +669.95% |
| August, 2027 | $5.3382 | $5.2182 | $7.2543 | +569.37% |
| September, 2027 | $0.0481 | $0.1519 | $5.4401 | -93.97% |
| October, 2027 | $0.3059 | $0.034 | $0.574 | -61.64% |
| November, 2027 | $1.5138 | $0.0218 | $1.6838 | +89.82% |
| December, 2027 | $2.1136 | $0.9758 | $2.1736 | +165.03% |
Verrica Pharmaceuticals Inc Stock (VRCA) Price Forecast for 2028
In 2028, Verrica Pharmaceuticals Inc (VRCA) is projected to reach an average price of $3.4773, with a high projection of $6.8316 and a low estimate of $0.1231. This indicates an +336.03% rise from the last price of $0.7975.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.0215 | $1.2656 | $2.2055 | +153.48% |
| February, 2028 | $1.0094 | $0.6874 | $2.5505 | +26.57% |
| March, 2028 | $0.5892 | $0.3972 | $1.3113 | -26.12% |
| April, 2028 | $0.6971 | $0.1231 | $1.0464 | -12.59% |
| May, 2028 | $0.6269 | $0.5469 | $1.613 | -21.39% |
| June, 2028 | $2.2748 | $0.4489 | $3.1728 | +185.24% |
| July, 2028 | $5.2326 | $2.2567 | $5.4977 | +556.13% |
| August, 2028 | $4.7025 | $4.4914 | $6.8316 | +489.65% |
| September, 2028 | $4.1903 | $4.0751 | $5.4044 | +425.43% |
| October, 2028 | $4.7082 | $3.7962 | $4.8743 | +490.37% |
| November, 2028 | $3.878 | $3.4161 | $5.1901 | +386.27% |
| December, 2028 | $3.9459 | $3.4759 | $4.692 | +394.78% |
Verrica Pharmaceuticals Inc Stock (VRCA) Price Forecast for 2029
The 2029 price forecast for Verrica Pharmaceuticals Inc Stock (VRCA) is $3.5089 on average, with a high prediction of $5.9368 and a low estimate of $1.0811. This represents an +339.99% increase from the previous price of $0.7975.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.0257 | $2.9338 | $5.9368 | +404.79% |
| February, 2029 | $2.6836 | $2.4236 | $4.0077 | +236.50% |
| March, 2029 | $2.2514 | $2.1914 | $3.0075 | +182.31% |
| April, 2029 | $1.8593 | $1.7893 | $2.3634 | +133.14% |
| May, 2029 | $1.2941 | $1.2291 | $2.3272 | +62.28% |
| June, 2029 | $2.047 | $1.0811 | $2.175 | +156.68% |
| July, 2029 | $5.5549 | $1.7609 | $5.7449 | +596.54% |
| August, 2029 | $3.8947 | $3.6153 | $5.5235 | +388.37% |
| September, 2029 | $3.4326 | $3.0126 | $4.0667 | +330.42% |
| October, 2029 | $3.2724 | $2.8624 | $4.3045 | +310.33% |
| November, 2029 | $5.2503 | $3.0444 | $5.5883 | +558.34% |
| December, 2029 | $4.55 | $3.96 | $5.8542 | +470.53% |
Verrica Pharmaceuticals Inc Stock (VRCA) Price Forecast for 2030
Verrica Pharmaceuticals Inc Stock (VRCA) is expected to reach an average price of $8.2308 in 2030, with a high forecast of $14.20 and a low forecast of $2.2657. This signifies an +932.07% surge from the last price of $0.7975.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.8497 | $2.2657 | $5.5697 | +508.11% |
| February, 2030 | $6.4554 | $4.2727 | $7.9315 | +709.45% |
| March, 2030 | $5.9311 | $5.4443 | $7.8811 | +643.72% |
| April, 2030 | $5.1969 | $3.8529 | $6.9851 | +551.64% |
| May, 2030 | $10.01 | $4.6108 | $11.21 | +1,155% |
| June, 2030 | $10.15 | $8.7023 | $11.40 | +1,173% |
| July, 2030 | $10.38 | $8.4006 | $11.23 | +1,202% |
| August, 2030 | $11.13 | $8.1337 | $14.20 | +1,295% |
| September, 2030 | $10.67 | $9.6934 | $12.70 | +1,238% |
| October, 2030 | $10.65 | $9.5952 | $13.09 | +1,236% |
| November, 2030 | $4.1788 | $2.8088 | $10.78 | +423.99% |
| December, 2030 | $5.7495 | $2.4927 | $7.5766 | +620.94% |
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):